Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FASN | P49327 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | FAAH | O00519 | 4/20 | 0.51 |
| ▸ | CNR1 | P21554 | 2/20 | 0.50 |
| ▸ | CNR2 | P34972 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL118480 | 1.00 | FASN (0.53) | FASNKDM4EMAPTFAAHCNR1 | |
| SCHEMBL117739 | 1.00 | FASN (0.53) | FASNKDM4EMAPTFAAHCNR1 | |
| SCHEMBL1503636 | 1.00 | FASN (0.53) | FASNKDM4EMAPTFAAHCNR1 | |
| SCHEMBL650656 | 1.00 | FASN (0.53) | FASNKDM4EMAPTFAAHCNR1 | |
| SCHEMBL118129 | 1.00 | FASN (0.53) | FASNKDM4EMAPTFAAHCNR1 | |
| SCHEMBL18297784 | 1.00 | FASN (0.53) | FASNKDM4EMAPTFAAHCNR1 | |
| SCHEMBL23921985 | 1.00 | FASN (0.53) | FASNKDM4EMAPTFAAHCNR1 | |
| SCHEMBL18297783 | 1.00 | FASN (0.53) | FASNKDM4EMAPTFAAHCNR1 | |
| SCHEMBL118128 | 1.00 | FASN (0.53) | FASNKDM4EMAPTFAAHCNR1 | |
| SCHEMBL2801944 | 1.00 | FASN (0.53) | FASNKDM4EMAPTFAAHCNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 934 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4554939-A1 | PCSK9 INHIBITORS AND METHODS OF USE THEREOF | Astrazeneca AB (SE) | 2025-05-21 | — | — | EP | claimed |
| CN-119977791-A | Method for separating saturated and unsaturated fatty acid and application thereof | 湖南万全裕湘生物科技有限公司 | 2025-05-13 | — | — | CN | claimed |
| CN-119604494-A | PCSK9 inhibitors and methods of use thereof | 阿斯利康(瑞典)有限公司 | 2025-03-11 | — | — | CN | claimed |
| CN-119015434-A | Complex for preventing, preventing or treating microbial infection, preparation method and application thereof | 太阳雨林(北京)生物医药有限公司 | 2024-11-26 | — | — | CN | claimed |
| EP-3886907-B1 | SEMIFLUORINATED ALKANE COMPOSITIONS COMPRISING OMEGA-3 FATTY ACID ETHYL ESTERS | NOVALIQ GMBH (DE) | 2024-10-02 | — | — | EP | claimed |
| CN-117800839-A | Composition containing eicosapentaenoic acid ethyl ester and preparation method and application thereof | 浙江可明生物医药有限公司 | 2024-04-02 | — | — | CN | claimed |
| US-20240058293-A1 | Nutritional Formulas Comprising Medium Chain Fatty Acids or Esters Thereof and Methods Related Thereto | UNIV EMORY (US) | 2024-02-22 | — | — | US | claimed |
| WO-2024013209-A1 | PCSK9 INHIBITORS AND METHODS OF USE THEREOF | ASTRAZENECA AB (SE) | 2024-01-18 | — | — | WO | claimed |
| US-11826336-B2 | Nutritional formulas comprising medium chain fatty acids or esters thereof and methods related thereto | EMORY UNIVERSITY (US) | 2023-11-28 | — | — | US | claimed |
| EP-3817568-B1 | METHOD FOR OBTAINING PURIFIED FATTY ACID ESTER COMPOSITION AND FATTY ACID ESTER COMPOSITION | ONESANO S A (PL) | 2023-09-13 | — | — | EP | claimed |
| CN-1084380-C | Process for producing refined fish oil with high polyenoic acid ethyl ester content from crude fish oil | ZHU HUIXIANG (CN) | 2002-05-08 | — | — | CN | claimed |
| EP-1152755-B1 | ESSENTIAL FATTY ACIDS IN THE PREVENTION OF CARDIOVASCULAR EVENTS | PHARMACIA & UPJOHN SPA (IT) | 2002-04-17 | — | — | EP | claimed |
| EP-1152755-A1 | ESSENTIAL FATTY ACIDS IN THE PREVENTION OF CARDIOVASCULAR EVENTS | PHARMACIA & UPJOHN S.p.A. (IT) | 2001-11-14 | — | — | EP | claimed |
| WO-2000048592-A1 | ESSENTIAL FATTY ACIDS IN THE PREVENTION OF CARDIOVASCULAR EVENTS | PHARMACIA & UPJOHN S.P.A. (IT) | 2000-08-24 | — | — | WO | claimed |
| CN-1263145-A | Process for producing refined fish oil with high polyenoic acid ethyl ester content from crude fish oil | ZHU HUIXIANG (CN) | 2000-08-16 | — | — | CN | claimed |
| CN-1236773-A | Process for preparing and separating ethyl docosahexenoate and ethyl eicosapentaenoate | ZHANG QIDE (CN) | 1999-12-01 | — | — | CN | claimed |
| CN-1204638-A | Preparation of docosahexenoic acid and esterification technology | TIANHAILIN INDUSTRY CO LTD HUN (CN) | 1999-01-13 | — | — | CN | claimed |
| EP-0292846-B1 | A process for the extraction of docosahexaenoic acid ethyl ester from fish oils and pharmaceutical and/or dietetic compositions containing a mixture of docosahexaenoic and eicosapentaenoic acid ethyl esters | STAR OIL LTD (GB) | 1994-08-17 | — | — | EP | claimed |
| US-5120556-A | Adding defatted corn germ | IDEMITSU PETROCHEMICAL CO., LTD. (JP) | 1992-06-09 | — | — | US | claimed |
| EP-0292846-A2 | A process for the extraction of docosahexaenoic acid ethyl ester from fish oils and pharmaceutical and/or dietetic compositions containing a mixture of docosahexaenoic and eicosapentaenoic acid ethyl esters | STAR OIL LTD (GB) | 1988-11-30 | — | — | EP | claimed |